Chemoembolization for Hepatocellular Carcinoma

NCT02821533 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped Poor case accrual

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: TACE
DRUG: Cisplatin

Sponsor

Chinese University of Hong Kong